Bavarian Nordic — April 2019
-
Advaxis præsenterer positive resultater på deres prostatavaccine i kombination med PD1-inhibitoren Keytruda. Både vaccinen og kombinationen ligner meget BNs tilgang med Prostvac kombi. Dog skal der i Advaxis's resultater tages forbehold for tidlige data (Fase 1+2) og manglende kontrolarm. https://ir.advaxis.com/press-release/adxs-psa-combination-keytruda-prolonged-survival-metastatic-castration-resistant
-
Nogen der forstår det her.. Zealand Pharma, Public offering 200 mill usd!? https://zealandpharma.gcs-web.com/static-files/e53f48fb-4042-453a-a411-e3267a39a707
-
-
CITI mener man får pipeline som fuldkommen gratis calloption ved nuværende pris.. skal min fordobles for st være fair prissat i dagens marked
https://penge.borsen.dk/artikel/1/379506/citi_om_bavarian_nordic_lige_nu_faar_du_hele_pipelinen_gratis.html -
Servicemeddelelse: For at skrive på vores chats fra I-phone: Hold knappen for indlæs siden inden. Herefter spørger den om du vil indlæse det fulde site. Det svar du ja til, herefter kan du skrive i chatten. Eller tryk på den firkantede box med pil opad i bunden af skærmbilledet. Tryk på "anmod om fulde websted".
-
Teva launches generic overactive bladder treatment
Solifenacin Succinate tablets treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
(en.globes.co.il)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind